文献速递关节外科创伤骨科

干预时机对急性术后假体周围感染DAIR失败的影响:美国人群层面分析

Impact of Intervention Timing on the Failure of Debridement, Antibiotics, and Implant Retention for Acute Postoperative Periprosthetic Joint Infections: A Contemporary United States Population-Level Analysis.
PubMed 文献 · J Arthroplasty · 2026-06-18

基于美国全国理赔数据库2010至2023年的回顾性队列研究,纳入7,795例初次全髋和全膝关节置换术后12周内因急性术后假体周围感染行DAIR的成人患者。结果显示DAIR失败率在术后4周内为37.7%,4至6周为40.1%(P=0.06),6至8周升至45.2%,8至10周为50.4%,10至12周达55.2%(均P<0.001);分段回归识别出约7周的拐点,超过此阈值失败风险显著加速上升,且该效应主要由全膝关节置换驱动。

要点

  • DAIR失败率在术后约7周内保持稳定,超过7周后失败风险显著加速上升。
  • 10至12周行DAIR的调整比值比为2.12(95%CI 1.73–2.58),失败风险最高。
  • 时间依赖效应主要由全膝关节置换驱动,全髋关节置换未见同等程度升高。

核心结论

  • 急性术后假体周围感染的DAIR疗效具有时间依赖性,术后约7周内结局稳定,超过此阈值干预失败风险不成比例增高,研究结果与2025年ICM推荐一致。

研究设计与样本

  • 回顾性队列研究,使用美国全国理赔数据库(2010至2023年),纳入初次全髋和全膝关节置换术后12周内因急性术后假体周围感染行DAIR的成人患者,共7,795例DAIR手术,按2周间隔分层(以不足4周为参照),采用多变量逻辑回归和分段回归分析。

主要发现

  • DAIR失败率在不足4周为37.7%,4至6周为40.1%(P=0.06),6至8周为45.2%,8至10周为50.4%,10至12周为55.2%(均P<0.001)。
  • 调整后4至6周失败比值比稳定(aOR 1.08;95%CI 0.94–1.25),10至12周升至最高(aOR 2.12;95%CI 1.73–2.58)。
  • 分段回归识别出关节置换术后约7周的拐点,超过该点风险显著加速上升。
  • 关节特异性分析显示该时间效应由全膝关节置换驱动,其DAIR失败率随干预时间延长而逐步升高。

关键数值与推荐

  • 治疗失败定义为术后2年内任何因感染行外科干预。
  • DAIR时机按2周间隔分层:不足4周、4至6周、6至8周、8至10周、10至12周,以不足4周为参照。

临床怎么用

  • 对于急性术后假体周围感染,应尽早在术后约7周内完成DAIR,超过7周后失败风险显著增加,尤其在全膝关节置换患者中需更严格把握干预时机。

局限性

  • 本研究为回顾性比较研究(证据等级III级),基于理赔数据库,可能存在编码偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Time to intervention is a critical determinant of failure after debridement, antibiotics, and implant retention (DAIR) in acute postoperative periprosthetic joint infection (PJI). While International Consensus Meeting (ICM) guidelines have expanded the recommended therapeutic window from 4 to 6 weeks, emerging European data suggest extension to 12 weeks. This study evaluated the association between DAIR timing and treatment failure after primary total hip and knee arthroplasties, leveraging a large United States database to identify an optimal threshold. METHODS: This was a retrospective cohort study using a national claims database (2010 to 2023) of adults with acute postoperative PJI undergoing DAIR within 12 weeks of primary total hip and knee arthroplasties. Patients were stratified into 2-week intervals (less than four weeks as reference). Treatment failure was any septic surgical intervention within 2 years. Multivariable logistic regressions adjusted for patient factors. Segmented regressions identified an inflection point. RESULTS: Among 7,795 DAIR procedures, failure rates were similar at less than four weeks (37.7%) and four to six weeks (40.1%; P = 0.06) but increased significantly thereafter: six to eight weeks (45.2%), eight to 10 weeks (50.4%), and 10 to 12 weeks (55.2%) (all P < 0.001). Adjusted odds of failure were stable at four to six weeks (aOR: 1.08; 95% confidence interval 0.94 to 1.25) but rose progressively, peaking at 10 to 12 weeks (aOR: 2.12; 95% confidence interval 1.73 to 2.58). Join point regression identified an inflection point at approximately 7 weeks postarthroplasty, beyond which risk accelerated significantly. Joint-specific analyses demonstrated this effect was driven by TKA, which showed progressively higher failure with increasing time to DAIR. CONCLUSIONS: DAIR efficacy for acute postoperative PJI is time-dependent. While outcomes remain stable through approximately 7 weeks after index arthroplasty, interventions beyond this threshold carry disproportionately higher failure risk. Our findings agree with the recommendations of the 2025 ICM. LEVEL OF EVIDENCE: Level III, Retrospective comparative study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Zedan AM, Barber T, Bini SA, et al. Impact of Intervention Timing on the Failure of Debridement, Antibiotics, and Implant Retention for Acute Postoperative Periprosthetic Joint Infections: A Contemporary United States Population-Level Analysis. J Arthroplasty. 2026. PMID: 42315062. doi:10.1016/j.arth.2026.06.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。